MDA Idea Awards
Funding Amount
Not stated
Deadline
Deadline not published
Grant Type
Foundation
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- Investigators from both US and non-US institutions are eligible to apply
Other requirements
- _You can learn more about this opportunity by visiting the funder's [website](https://www.mda.org/science/funding-opportunities)._
- Must hold a Doctor of Medicine (M.D.), Doctor of Philosophy (Ph
- D.), Doctor of Science (D.Sc.) or equivalent degree (i.e
- D.O.)
Overview
MDA is committed to transforming the lives of people affected by muscular dystrophy, ALS and related neuromuscular diseases. As the largest source of funding for neuromuscular disease research outside of the federal government, MDA has committed more than $1 billion since our inception to accelerate the discovery of therapies and cures. Research we have supported is directly linked to life-changing therapies across multiple neuromuscular diseases. In addition to the work MDA does to provide the best clinical care and support to families living with neuromuscular disease, funding the most promising and innovative research is a top priority.
MDA's Scientific Program
As the leader in neuromuscular disease research, MDA is more committed than ever to finding treatments and cures. Our scientific program seeks to:
- Support research at pivotal stages in development — from research into disease etiology and pathogenesis through to clinical trials.
- Concentrate research funding on projects which focus on therapy development or tackle key barriers to therapy development.
- Foster talented new investigators.
- Encourage companies to engage in neuromuscular disease research and drug development.
- Use an intentional and proactive approach to funding research.
- Facilitate collaboration among researchers, and support professional and educational opportunities.
MDA provides support for research throughout the pipeline of drug development from discovery research through clinical trials. Funding opportunities exist for both academic investigators as well as for biotech and pharma seeking to develop therapies for neuromuscular disease.
MDA Idea Awards
The MDA Idea Award Program seeks bold, innovative research ideas that can have an impact in the field of neuromuscular disease. The idea should be supported by a strong scientific premise and include a feasible experimental plan. Applications will be accepted for no more than $50,000 for one year.
Eligibility
_You can learn more about this opportunity by visiting the funder's website._
- Must hold a Doctor of Medicine (M.D.), Doctor of Philosophy (Ph.D.), Doctor of Science (D.Sc.) or equivalent degree (i.e. D.O.).
- Must be a professional or faculty member (Professor, Associate Professor or Assistant Professor) at an appropriate educational, medical or research institution.
- Investigators from both US and non-US institutions are eligible to apply. Applicants with non-traditional positions/titles (such Group Leader, Research Scientist, or Instructor etc.) should contact the grants manager ehabeeblouks@mdausa.org to confirm eligibility.
- Must be qualified to conduct a program of original research within their own laboratory;
- Must have an acceptable research plan for a specific disease in MDA's portfolio.
- Must assume both administrative and financial responsibility for the grant;
- Must have access to institutional resources necessary to conduct the proposed research project; and
- An investigator may only apply once per grant type (such as Research Grant, Idea, etc.) per cycle as the PI on the application.
- By the application deadline, applicants must be in compliance with MDA’s Good Standing policy and be up to date on any delinquent or incomplete grant deliverable from previously awarded grants. See MDA Research Department Grant Policy Manual for details.
What Muscular Dystrophy Association Inc actually gave
Source: IRS Form 990, 2025
- Grants in 2025
- 193
- Total given
- $12.57M
- Median grant
- $40K
- Range
- $6,025–$642K
- By dollars: California 13%, New York 10%, Massachusetts 7%. Top recipient cities: Atlanta, GA; Los Angeles, CA; Boston, MA.
- 0% of grants with a stated purpose were for general or operating support.
- 11% of recipients were new grantees, not repeat recipients.
Example grants
University of Washington Medical Center · Seattle, WA
Medical diagnosis
$642K
Johns Hopkins University- CG · Baltimore, MD
Medical diagnosis and research
$579K
The Regents of the University of California Los Angeles · La Jolla, CA
Medical diagnosis research and movr registry support
$411K
University of Rochester - · Rochester, NY
Research
$399K
Massachusetts General Hospital · Boston, MA
Medical diagnosis and research
$378K
Focus Areas & Funding Uses
Fields of Work
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
MDA Research Grants (Investigator-Initiated)
Muscular Dystrophy Association Inc
Amount
Varies; 2015 round: $10 million total across 36 grants
Deadline
Deadline not published
MDA Venture Philanthropy Program
Muscular Dystrophy Association Inc
Amount
Varies by project; example: $2 million for Phase 1 clinical trial
Deadline
Deadline not published
MDA Kickstart Program
Muscular Dystrophy Association Inc
Amount
Varies
Deadline
Deadline not published
Parkinson's Disease Therapeutics Pipeline Grant Program
The Michael J Fox Foundation for Parkinson's Research
Amount
US $250,000 - US $2,000,000
Deadline
October 30, 2026
Listed date — confirm with the funder
GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)
National Institutes of Health
Amount
$2,000,000 total
Deadline
October 30, 2026
GREGoRi Innovation Projects (U01 Clinical Trial Optional)
National Institutes of Health
Amount
$3 – $500K
Deadline
October 30, 2026
Ready to apply for MDA Idea Awards?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found MDA Idea Awards. Now let's win it.